Rottlerin inhibits P2X7 receptor-stimulated phospholipase D activity in chronic lymphocytic leukaemia B-lymphocytes

Immunology and Cell Biology

Volumn 85, Issue 1, 2007, Pages 68-72

  Shemon, Anne N ^a   Sluyter, Ronald ^a   Wiley, James S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

B lymphocyte; Chronic lymphocytic leukaemia; P2X7 receptor; Phospholipase D; Rottlerin

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADENOSINE TRIPHOSPHATE; ALANINE; GLUTAMIC ACID; ISOENZYME; MONOCLONAL ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE D; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; PURINE P2X7 RECEPTOR; RECEPTOR ANTIBODY; ROTTLERIN;

AMINO ACID SUBSTITUTION; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE FUNCTION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; REGULATORY MECHANISM;

ACETOPHENONES; ADENOSINE TRIPHOSPHATE; B-LYMPHOCYTES; BENZOPYRANS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, B-CELL, CHRONIC; PHOSPHOLIPASE D; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS; PROTEIN KINASE C; RECEPTORS, PURINERGIC P2; RUBIDIUM;

EID: 33846048059     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/sj.icb.7100005     Document Type: Article

References (41)

1. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 2004; 240: 31-304.
2. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002; 82: 1013-1067.
3. el-Moatassim C, Dubyak GR. A novel pathway for the activation of phospholipase D by P2z purinergic receptors in BAC1.2F5 macrophages. J Biol Chem 1992; 267: 23664-23673.
4. Gargett CE, Cornish EJ, Wiley JS. Phospholipase D activation by P2Z-purinoceptor agonists in human lymphocytes is dependent on bivalent cation influx. Biochem J 1996; 313: 529-535.
5. McDermott M, Morris AJ, Wakelam MJO. Phospholipase D. Biochem Cell Biol 2004; 82: 225-253.
6. Kusner DJ, Adams J. ATP-induced killing of virulent Mycobacterium tuberculosis within human macrophages requires phospholipase D. J Immunol 2000; 164: 379-388.
7. 7 receptors. J Neurochem 1999; 73: 334-343.
8. Perez-Andres E, Fernandez-Rodriguez M, Gonzalez M, Zubiaga A, Vallejo A, Garcia I et al. Activation of phospholipase D-2 by P2X(7) agonists in rat submandibular gland acini. J Lipid Res 2002; 43: 1244-1255.
9. 7 receptors in submandibular ductal cells. Cell Signal 2003; 15: 927-935.
10. 7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem 2004; 279: 16918-16926.
11. Gargett CE, Wiley JS. The isoquinoline derivative KN-62 a potent antagonist of the P2Z-receptor of human lymphocytes. Br J Pharmacol 1997; 120: 1483-1490.
12. Becker KP, Hannun YA. Protein kinase C and phosphoipase D: intimate interactions in intracellular signalling. Cell Mol Life Sci 2005; 62: 1448-1461.
13. 7 receptor. Br J Pharm 2004; 142: 1015-1019.
14. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 1998; 332: 281-292.
15. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
16. Davis PD, Elliot LH, Harris W, Hill CH, Hurst SA, Keech E et al. Inhibitors of protein kinase C. 2. Substituted bisindoylmaleimides with improved potency and selectivity. J Med Chem 1992; 35: 994-1001.
17. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G et al. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 1994; 199: 93-98.
18. 7 receptor function with a monoclonal antibody. Blood 1998; 92: 3521-3528.
19. 7 function and impairs ATP-induced mycobacterial killing by macrophages. J Biol Chem 2006; 281: 2079-2086.
20. 7 receptor. J Biol Chem 2001; 276: 11135-11142.
21. 7 receptor. J Biol Chem 2004; 279: 44749-44755.
22. 7 receptor impairs ATP-induced IL-1b release from human monocytes. J Immunol 2004; 172: 3399-3405.
23. Wilkinson SE, Parker PJ, Nixon JS. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 1993; 294: 335-337.
24. Exton JH. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol 2002; 144: 1-94.
25. Ringshausen I, Schneller F, Bogner C, Hipp S, Duyster J, Peschel C et al. Constitutively activated phosphatidylinositol-3 kinase (PI-3 K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta. Blood 2002; 100: 3741-3748.
26. Alkan S, Huang Q, Ergin M, Denning F, Nand S, Maududi T et al. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Am J Hematol 2005; 79: 97-106.
27. Parekh DB, Ziegler W, Parker PJ. Multiple pathways control protein kinase C phosphorylation. EMBO J 2000; 19: 496-503.
28. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 1998; 281: 2042-2045.
29. 7 receptors activate protein kinase D and p42/p44 mitogen activated kinase (MAPK) downstream of protein kinase C. Biochem J 2002; 366: 745-755.
30. 7 receptor-mediated phospholipase D activation is regulated by both PKC-dependent and PKC-independent pathways in a rat brain-derived Type-2 astrocyte cell line, RBA-2. Cell Signal 2002; 14: 83-92.
31. Soltoff SP. Rottlerin is a mitochondrial uncoupler that decreases cellular ATP levels and indirectly blocks protein kinase C delta tyrosine phosphorylation. J Biol Chem 2001; 276: 37986-37992.
32. 7 nucleotide receptor. J Biol Chem 2000; 275: 26792-26798.
33. 7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J Leokoc Biol 2004; 75: 1173-1182.
34. 2z purinergic receptors in BAC1.2F5 macrophages. Product inhibition of phospholipase D enzyme activity. J Biol Chem 1993; 268: 15571-15578.
35. 7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and INF-gamma in the human THP-1 monocytic cell line. J Immunol 1996; 157: 5627-5637.
36. Divald A, Karl PI, Fisher SE. Regulation of phospholipase D in human placental trophoblasts by the P(2) purinergic receptor. Placenta 2002; 23: 584-593.
37. Sluyter R, Barden JA, Wiley JS. Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 2001; 304: 231-236.
38. Kusner DJ, Barton JA. ATP stimulates human macrophages to kill intracellular virulent mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion. J Immunol 2001; 167: 3308-3315.
39. Fairbairn IP, Stober CB, Kumararatne DS, Lammas DA. ATP-mediated killing of intracellular mycobacteria by macrophages is a P2X(7)-dependent process inducing bacterial death by phagosome-lysosome fusion. J Immunol 2001; 167: 3300-3307.
40. 7 receptor abolishes ATP-mediated killing of Mycobacteria. J Immunol 2003; 171: 5442-5446.
41. 7 receptor on adenosine triphosphate-mediated killing of mycobacteria by human macrophages. J Infect Dis 2005; 192: 149-155.